Chronic Obstructive Pulmonary Disease (COPD)
![pictured: a man clutches his chest with one hand and coughs into his fist](https://www.wakeclinical.com/wp-content/uploads/2023/03/copd.jpg)
COPD Research Study
ClinSearch is comparing two inhaler treatments on patients with Moderate to Severe COPD with cardiovascular disease or risk.
To qualify, you must:
- Be 40-80 years old
- Have Moderate to Severe COPD without an exacerbation within 8 weeks and no history of Asthma lifetime or lung cancer within 5 years
- History of smoking
- No history of Asthma
- No history of Lung Cancer
- Have pre-existing CVD or high-risk CVD conditions (Hypertension, Diabetes, Obesity, etc.)
Qualified participants may receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- May receive compensation for time
![pictured: a man clutches his chest with one hand and coughs into his fist](https://www.wakeclinical.com/wp-content/uploads/2023/03/copd-featured.jpg)
![](https://www.wakeclinical.com/wp-content/uploads/2023/02/white-square.png)
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/5.jpg)
Why Participate?
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/2.jpg)
Experience
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/4.jpg)
Safety
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.
![](https://www.wakeclinical.com/wp-content/uploads/2022/12/news-bg.jpg)
ClinSearch
Study Hotline
+1-423-347-6279
Main Office
+1-423-698-4584
Our Hours
Mon-Fri: 8AM to 5PM
Location
6035 Shallowford Rd. Suite #109
Chattanooga, TN 37421